Unveiling the eligibility for screening of cardiac amyloidosis in a real world population

Back

HFA Premium Access

Unveiling the eligibility for screening of cardiac amyloidosis in a real world population

Session: Valvular heart disease 4

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor F. Gerardo (Amadora, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Filipa Gerardo

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

2 presentations

0 follower

6 more presentations in this session

The main predictors of in-hospital mortality in patients with infective endocarditis: a retrospective single-center study.

Speaker: Doctor N. Ilchyshyn (Almada, PT)

Transcatheter aortic valve replacement for low-flow, low-gradient aortic stenosis: unravelling the impact of contractile reserve on survival

Speaker: Doctor T. Pereira dos Santos (Coimbra, PT)

Coronary artery calcium score and prognosis in patients undergoing transcatheter aortic valve replacement

Speaker: Doctor V. Lopes (Coimbra, PT)

Long-term echocardiographic outcomes: the role of valve-sparing and valve-replacing approaches

Speaker: Miss V. Zieniute (Kaunas, LT)

Aortic valve calcification as a surrogate parameter for paravalvular regurgitation following transcatheter aortic valve implantation

Speaker: Doctor F. Duarte (Ponta Delgada, PT) Doctor R. Teixeira (Vila Nova de Gaia, PT)

Access the full session

Valvular heart disease 4

Speakers: Doctor F. Gerardo, Doctor N. Ilchyshyn, Doctor T. Pereira dos Santos, Doctor V. Lopes, Miss V. Zieniute...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources